ArcticLine Feasibility Study
Sponsor: Medtronic Cardiac Ablation Solutions
This NA trial investigates Atrial Fibrillation and Atrial Flutter and is currently completed. Medtronic Cardiac Ablation Solutions leads this study, which shows 15 recorded versions since 2018 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Mar 2025 — Sep 2025 [monthly]
Completed NA
-
Sep 2024 — Mar 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
▶ Show 10 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Jun 2020 — Jan 2021 [monthly]
Completed NA
-
Feb 2020 — Jun 2020 [monthly]
Completed NA
-
Jan 2020 — Feb 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2019 — Jan 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2019 — Jun 2019 [monthly]
Recruiting NA
-
Dec 2018 — Jan 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2018 — Dec 2018 [monthly]
Not Yet Recruiting NA
-
Aug 2018 — Oct 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Ablation Solutions
For direct contact, visit the study record on ClinicalTrials.gov .